NasdaqGS - Nasdaq Real Time Price USD
PMV Pharmaceuticals, Inc. (PMVP)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 7:43 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.36 | -0.38 | -1.05 | -1.65 |
| Low Estimate | -0.39 | -0.45 | -1.15 | -1.92 |
| High Estimate | -0.33 | -0.31 | -0.92 | -1.41 |
| Year Ago EPS | -0.34 | -0.31 | -1.44 | -1.05 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.45 | -0.39 | -0.36 | -0.35 |
| EPS Actual | -0.34 | -0.31 | -0.3 | -0.02 |
| Difference | 0.11 | 0.08 | 0.06 | 0.33 |
| Surprise % | 24.40% | 20.50% | 16.70% | 94.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.36 | -0.38 | -1.05 | -1.65 |
| 7 Days Ago | -0.36 | -0.38 | -1.05 | -1.65 |
| 30 Days Ago | -0.36 | -0.38 | -1.05 | -1.65 |
| 60 Days Ago | -0.36 | -0.38 | -1.05 | -1.65 |
| 90 Days Ago | -0.36 | -0.37 | -1.37 | -1.57 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PMVP | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -5.90% | -- | -- | 3.70% |
| Next Qtr. | -22.60% | -- | -- | 7.90% |
| Current Year | 27.10% | -- | -- | 2.50% |
| Next Year | -57.10% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 23.10% | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/30/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/14/2024 |
| Initiated | Craig-Hallum: Buy | 5/13/2024 |
| Initiated | Jefferies: Buy | 4/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
Related Tickers
ACHL Achilles Therapeutics plc
1.0000
+1.01%
SEER Seer, Inc.
1.9300
-0.52%
BOLT Bolt Biotherapeutics, Inc.
0.6264
-1.82%
ANTX AN2 Therapeutics, Inc.
1.0500
+1.94%
GLTO Galecto, Inc.
7.12
+5.79%
TBPH Theravance Biopharma, Inc.
8.80
+2.09%
KROS Keros Therapeutics, Inc.
61.25
+0.26%
HLVX HilleVax, Inc.
1.8800
+0.53%
ALVR AlloVir, Inc.
0.7731
0.00%
LVTX LAVA Therapeutics N.V.
1.6800
+1.82%